South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market 2023 Share, Size, Key Players, Revenue Analysis | Prudent Markets

The South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics market. This report explores all the key factors affecting the growth of the global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141679/

Report Overview

The South Korea non-alcoholic steatohepatitis therapeutics (NASH) market size stood at around USD xx billion in 2019 and is projected to reach xx billion by 2028, exhibiting a CAGR of around 6.5% during the forecast period.

The prevalence of non-alcoholic fatty liver disease (NAFLD) in Korea is about 30 percent. NAFLD progresses into NASH. Non-alcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic or consume little alcohol. NASH is one of the common liver diseases, often called silent liver disease. It is characterized by cell injury, inflammatory cell infiltration and hepatocyte ballooning that may further progress to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC).

NASH is expected to surpass hepatitis C virus infection as the leading aetiology of end-stage liver disease requiring liver transplantation in coming years. It is also currently the leading aetiology driving the burden of hepatocellular carcinoma.

Market Drivers

Increase in prevalence of NASH, strong presence of ideal pipeline molecules, higher number of unmet needs, and growth in awareness of NASH therapeutics will fuel the market drive of NASH therapeutics during the forecasted period.

Furthermore, rise in prevalence of chronic diseases like diabetes and obesity, is expected to influence the market growth. On the other hand, lack of diagnostic technologies for NASH limit the growth of the market.

To Know More About COVID-19 Impact On South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market @ https://www.prudentmarkets.com/sample-request/141679/

Market Segmentation

By Drug Type:

On the basis of drug type market is segmented as PPAR agonists, FXR- bile acid agents (obeticholic acid), anti- Inflammatory (cenicriviroc), antioxidants (Vitamin E, PTX) and anti-fibrotic (simtuzumab). PPAR agonists include elafibranor, pioglitazone and saroglitazar.

At present, there is no FDA-approved drug to treat NASH. Vitamin E & pioglitazone are used as first line drugs, they dominate the NASH market, due to efficacy. On the other hand, elafibranor and cenicriviroc segments are expected to exhibit significant growth in the future, majorly due to its effectiveness in severely affected NASH patients.

By Sales Channel:

According to sales channel NASH therapeutics market is segmented into hospital, retail, and online pharmacies.

Top Players

Despite the significant burden to the public health system, there are no FDA-approved drugs that are specifically tailored for this condition. Therefore, the need for effective treatment that manages the complex pathophysiologic processes of NASH, can no longer be ignored. Several novel medications targeting different stages and molecular events in the disease process are currently in the pipeline, while other previously known off-label treatments are still used.

Domestic companies developing non-alcoholic steatohepatitis specific treatments include Yuhan Corporation, Dong-A ST, ST Pharm, Hanmi Pharmaceutical, NG Chem Life Science, Samil Pharmaceutical, Huons, Pharma king, CJ Healthcare (Kolmar Korea), and LG Chem.

Highlighted Segments of South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market:

Industry Overview: The first section of the research study covers an overview of the global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market, market status and prospects, and product range. In addition, it provides highlights of the major segments of the global Market, i.e., region, type, and application segments.

Competitive Analysis: This report illuminates important mergers and acquisitions, business expansion, product or service differences, market concentration, the competitive status of the global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market, and market size by player.

Company Profiles and Key Data: This section covers companies profiling the major players in the global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market based on the aforementioned revenue, products, business, and other factors.

Market size by type and application: In addition to providing an in-depth analysis of the industry size by type and application, this section provides research on top end users or consumers and potential applications.

Market Dynamics: This report covers the drivers, trends, and opportunities of the global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market. This section also includes Porter's analysis of five forces.

Findings and Conclusions: It provides strong recommendations for new as well as established players for securing a position of strength in the global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141679/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics market
Chapter 2: Exclusive Summary - the basic information of the South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics
Chapter 4: Presenting the South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Why should you purchase this report?

-Prudent Markets provides the vital historical and analysis data of global South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics market.
-The report provides the entire assessment of the future market and altering market scenario or behavior.
-All the business decision could be backed through the several strategic business methodologies offered in the report.
-An extra edge in the competitive market could be obtained from this elaborative research report
-The report offers all the competitive landscape, growth drivers, applications, market dynamics, and other necessary details as well.

Purchase this report (Single User License) @ https://www.prudentmarkets.com/checkout/?id=141679&license_type=su

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the South Korea Non-Alcoholic Steatohepatitis (NASH) Therapeutics Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.